期刊文献+

褪黑素抗肿瘤作用及其机制的研究进展 被引量:9

Melatonin in the treatment of cancer and its mechanism
下载PDF
导出
摘要 褪黑素(melatonin,MT)是主要由松果腺分泌的神经内分泌激素,具有调节生理节奏、免疫调节、抗氧化和抗炎等多种生理功能。近年来大量文献表明MT具有抗肿瘤和化学预防作用,MT的抗肿瘤作用研究已经成为热点,其中包括对乳腺癌、黑色素瘤、结肠癌和前列腺癌等肿瘤的研究。证据表明多种机制参与了MT的抗肿瘤作用,例如干扰雌激素的信号转导和影响端粒酶活性等。MT不仅具有单独的抑瘤作用,而且在肿瘤辅助治疗中具有增效、降毒作用。 Melatonin, a neuroendoerine hormone secreted by the pineal gland, is involved in numerous physiological processes including circadian rhythms, immune function, antioxidant and anti-inflammatory activities. This overview summarizes the growing evidences of melatonin as a promising agent for cancer treatment and possible cancer prevention. To date, the chemopreventive, oncostatic, and tumor inhibitory effects of melatonin have become a hot area of investigation, particularly in breast cancer,melanoma, colon cancer, lung cancer and prostatic carcinoma. Multiple mechanisms including interacting with the estrogen-signaling pathways and affecting telomerase activation have been suggested for the biological effects of melatonin. Melatonin not only seems to control development alone but is highlighted in increasing the efficacy and decreasing the side effects of chemotherapy when used in adjuvant therapeutics.
作者 胡世莲
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第4期428-431,共4页 Chinese Pharmacological Bulletin
基金 安徽省2006年科技攻关资助项目(No06013126B)
关键词 褪黑素 肿瘤 机制 melatonin tumor mechanism
  • 相关文献

参考文献25

  • 1Stevens R G. Circadian disruption and breast cancer: from melatonin to clock genes[ J]. Epidemiology, 2005,16 (2) :254 - 8.
  • 2Schernhammer E S, Hankinson S E. Urinary melatonin levels and breast cancer risk[ J]. J Natl Cancer Inst, 2005,97( 14 ) : 1084 - 7.
  • 3Pinheiro S P,Sehemhammer E S,Tworoger S S,Michels K B. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women[ J]. Cancer Res, 2006,66 (10) :5521 -5.
  • 4Lenoir V, de Jonage-Canonico M B, Perrin M H,et al. Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat[J]. Breast Cancer Res, 2005,7(4) :R470 -6.
  • 5De Jonage-Canonico M B, Lenoir V, Martin A, et al. Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a) anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis[ J ]. Breast Cancer Res Treat, 2003,79( 3 ) :365 - 77.
  • 6Cos S, Mediavilla D, Martinez-Campa C, et al. Exposure to lightat-night increases the growth of DMBA-induced mammary adenocarcinomas in rats[J]. Cancer Lett, 2006,235(2 ) :266 -71.
  • 7Collins A, Yuan L, Kiefer T L, et al. Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice [ J ]. Cancer Lett, 2003, 189( 1 ) :49 - 57.
  • 8Girgert R, Bartsch C, Hill S M, et al. Tracking the elusive an- tiestrogenic effect of melatonin: a new methodological approach [J]. Neuro Endocrinol Lett, 2003,24(6) :440 -4.
  • 9Cos S, Martinez-Campa C, Mediavilla M D, et al. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells [J]. J Pineal Res, 2005,38(2) :136 -42.
  • 10Saez M C, Barriga C, Garcia J J, et al. Melatonin increases the survival time of animals with untreated mammary tumours : Neuroendocrine stabilization[ J]. Mol Cell Biochem, 2005,278( 1 -2 ) : 15 -20.

同被引文献119

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部